EACR Cancer genomics, multiomics and computational biology

Visit us at booth #2

Reveal the power of the 6-base genome – introducing duet multiomics solution evoC

30 April 2024
to 2 May 2024

Centro Congressi Giovanni XXII, Bergamo

About the event

The EACR conference on Cancer Genomics was widely recognised as the premier European conference dedicated to cancer genomics. In 2024, we are renaming the conference and evolving its content to cover the latest exciting developments: machine learning and artificial intelligence, single cell and spatial analysis of cancers, cell plasticity, cancer immune genomics, data integration and convergence, epigenetics, and genomic instability.

Featuring an exceptional international faculty and extensive networking opportunities, this conference will provide both the possibility and intimate setting for top quality scientific interaction.

Combined genetic and epigenetic analyses of a Lynch syndrome tumour

Dr. Jacob Househam

Data Scientist

The Institute of Cancer Research

Tuesday 30 April, 2024 | 16:40-17:10

Presentation abstract

Coming soon!

One sample. One workflow. One solution.

Here are the relevant biomodal resources for information. Find poster presentation information, case studies, interviews, and more.

duet multiomics solution evoC product sheet

duet multiomics solution evoC product sheet

Novel single-base-resolution solution that delivers the standard four-base sequencing (A, C, G, and T), and distinguishes between 5‑methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC), on the same DNA molecule.

Related resources

Deep, targeted simultaneous sequencing of genetics and epigenetics in DNA

Deep, targeted simultaneous sequencing of genetics and epigenetics in DNA

DNA comprises molecular information stored in genetic and epigenetic bases, both of which are vital to our understanding of biology. The interplay between genetics and the DNA epigenome orchestrates complex biological phenomena as diverse as cell fate, ageing, the response to environmental stimuli, and disease pathogenesis.

Attending from biomodal

Business Development Director
Director of Sales and Business Development, Europe
EACR Bergamo Apr 2024

Get in touch

Cambridge Epigenetix is now biomodal